Follow
Helen Fletcher
Helen Fletcher
Verified email at lshtm.ac.uk - Homepage
Title
Cited by
Cited by
Year
Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans
H McShane, AA Pathan, CR Sander, SM Keating, SC Gilbert, K Huygen, ...
Nature medicine 10 (11), 1240-1244, 2004
7842004
Upregulation of TGF-β, FOXP3, and CD4+ CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection
M Walther, JE Tongren, L Andrews, D Korbel, E King, H Fletcher, ...
Immunity 23 (3), 287-296, 2005
4832005
Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA− NP+ M1
TK Berthoud, M Hamill, PJ Lillie, L Hwenda, KA Collins, KJ Ewer, A Milicic, ...
Clinical infectious diseases 52 (1), 1-7, 2011
3562011
T-cell activation is an immune correlate of risk in BCG vaccinated infants
HA Fletcher, MA Snowden, B Landry, W Rida, I Satti, SA Harris, ...
Nature communications 7 (1), 11290, 2016
3092016
Recognition of Stage-Specific Mycobacterial Antigens Differentiates between Acute and Latent Infections with Mycobacterium tuberculosis
A Demissie, EMS Leyten, M Abebe, L Wassie, A Aseffa, G Abate, ...
Clinical and vaccine immunology 13 (2), 179-186, 2006
2742006
Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4δ2
A Demissie, M Abebe, A Aseffa, G Rook, H Fletcher, A Zumla, K Weldingh, ...
The Journal of Immunology 172 (11), 6938-6943, 2004
2562004
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa
T Hawkridge, TJ Scriba, S Gelderbloem, E Smit, M Tameris, S Moyo, ...
The Journal of infectious diseases 198 (4), 544-552, 2008
2232008
COVID-19 as a global challenge: towards an inclusive and sustainable future
H Lambert, J Gupte, H Fletcher, L Hammond, N Lowe, M Pelling, N Raina, ...
The Lancet Planetary Health 4 (8), e312-e314, 2020
2192020
Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials
H McShane, AA Pathan, CR Sander, NP Goonetilleke, HA Fletcher, ...
Tuberculosis 85 (1-2), 47-52, 2005
1772005
Human immunology of tuberculosis
TJ Scriba, AK Coussens, HA Fletcher
Microbiology spectrum 5 (1), 10.1128/microbiolspec. tbtb2-0016-2016, 2017
1572017
Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study
JR Andrews, E Nemes, M Tameris, BS Landry, H Mahomed, JB McClain, ...
The lancet Respiratory medicine 5 (4), 282-290, 2017
1472017
Ratio of monocytes to lymphocytes in peripheral blood identifies adults at risk of incident tuberculosis among HIV-infected adults initiating antiretroviral therapy
V Naranbhai, AVS Hill, SS Abdool Karim, K Naidoo, Q Abdool Karim, ...
The Journal of infectious diseases 209 (4), 500-509, 2014
1452014
Association of human antibodies to arabinomannan with enhanced mycobacterial opsonophagocytosis and intracellular growth reduction
T Chen, C Blanc, AZ Eder, R Prados-Rosales, ACO Souza, RS Kim, ...
The Journal of infectious diseases 214 (2), 300-310, 2016
1382016
Molecular analysis of Mycobacterium tuberculosis DNA from a family of 18th century Hungarians
HA Fletcher, HD Donoghue, G Michael Taylor, AGM van der Zanden, ...
Microbiology 149 (1), 143-151, 2003
1372003
TB vaccine development and the End TB Strategy: importance and current status
HA Fletcher, L Schrager
Transactions of the Royal Society of Tropical Medicine and Hygiene 110 (4 …, 2016
1262016
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses
A Ogbe, B Kronsteiner, DT Skelly, M Pace, A Brown, E Adland, K Adair, ...
Nature communications 12 (1), 2055, 2021
1252021
Perspectives on advances in tuberculosis diagnostics, drugs, and vaccines
M Schito, GB Migliori, HA Fletcher, R McNerney, R Centis, L D'Ambrosio, ...
Clinical infectious diseases 61 (suppl_3), S102-S118, 2015
1252015
A helicopter perspective on TB biomarkers: pathway and process based analysis of gene expression data provides new insight into TB pathogenesis
SA Joosten, HA Fletcher, THM Ottenhoff
PloS one 8 (9), e73230, 2013
1212013
Sensitivity of IFN-γ release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression
F Karam, F Mbow, H Fletcher, CS Senghor, KD Coulibaly, AM LeFevre, ...
PLoS One 3 (1), e1441, 2008
1202008
Progress and challenges in TB vaccine development
G Voss, D Casimiro, O Neyrolles, A Williams, SHE Kaufmann, H McShane, ...
F1000Research 7, 2018
1172018
The system can't perform the operation now. Try again later.
Articles 1–20